BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23419000)

  • 1. Opportunities and challenges: over-the-counter codeine supply from the codeine consumer's perspective.
    Nielsen S; Cameron J; Pahoki S
    Int J Pharm Pract; 2013 Jun; 21(3):161-8. PubMed ID: 23419000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs.
    Arora S; Roxburgh A; Bruno R; Nielsen S; Burns L
    Drug Alcohol Rev; 2013 Nov; 32(6):574-81. PubMed ID: 23751176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies.
    Van Hout MC; Norman I
    Int J Drug Policy; 2016 Jan; 27():17-22. PubMed ID: 26454626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention.
    Nielsen S; Cameron J; Lee N
    J Opioid Manag; 2011; 7(5):363-70. PubMed ID: 22165035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The upscheduling of combination analgesics containing codeine: the impact on the practice of pharmacists.
    Hamer AM; Spark MJ; Wood PJ; Roberts E
    Res Social Adm Pharm; 2014; 10(4):669-78. PubMed ID: 24144932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing inappropriate use of non-prescription combination analgesics containing codeine: A modified Delphi study.
    Gibbins AK; Wood PJ; Spark MJ
    Res Social Adm Pharm; 2017; 13(2):369-377. PubMed ID: 27084506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'For pain, no shame' and 'My secret solace': Accounts of over-the-counter codeine dependence using Q methodology.
    Kirschbaum M; Barnett T; Cross M
    Int J Drug Policy; 2019 Nov; 73():121-128. PubMed ID: 31654934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supply of codeine combination analgesics from Australian pharmacies in the context of voluntary real-time recording and regulatory change: A simulated patient study.
    Collins JC; Hillman JM; Schneider CR; Moles RJ
    Int J Drug Policy; 2019 Dec; 74():216-222. PubMed ID: 31677483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a clinical tool to assess and address pain management requests in the pharmacy.
    Wood P; Tucci J; Anderson K; Mnatzaganian G
    Res Social Adm Pharm; 2019 Jul; 15(7):852-857. PubMed ID: 30611648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.
    Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA
    Med J Aust; 2020 Apr; 212(7):321-327. PubMed ID: 32200566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-prescription supply of combination analgesics containing codeine in community pharmacy: A simulated patient study.
    Byrne GA; Wood PJ; Spark MJ
    Res Social Adm Pharm; 2018 Jan; 14(1):96-105. PubMed ID: 28283305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions to enhance effective communication during over-the-counter consultations in the community pharmacy setting: A systematic review.
    Seubert LJ; Whitelaw K; Hattingh L; Watson MC; Clifford RM
    Res Social Adm Pharm; 2018 Nov; 14(11):979-988. PubMed ID: 29258734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia.
    Gisev N; Nielsen S; Cama E; Larance B; Bruno R; Degenhardt L
    Eur J Clin Pharmacol; 2016 Apr; 72(4):469-94. PubMed ID: 26690771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why aren't Australian pharmacists supplying naloxone? Findings from a qualitative study.
    Olsen A; Lawton B; Dwyer R; Taing MW; Chun KLJ; Hollingworth S; Nielsen S
    Int J Drug Policy; 2019 Jul; 69():46-52. PubMed ID: 31078908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of evidence-based medicine training on decision-making in relation to over-the-counter medicines: a qualitative study.
    Hanna LA; Hughes C
    Int J Pharm Pract; 2012 Dec; 20(6):358-66. PubMed ID: 23134094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misuse of OTC drugs in Poland.
    Zaprutko T; Koligat D; Michalak M; Wieczorek M; Józiak M; Ratajczak M; Szydłowska K; Miazek J; Kus K; Nowakowska E
    Health Policy; 2016 Aug; 120(8):875-81. PubMed ID: 27344198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons centre.
    Cairns R; Brown JA; Buckley NA
    Addiction; 2016 Oct; 111(10):1848-53. PubMed ID: 27177599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of nonprescription medicines among elderly patients with chronic illness and their need for pharmacist interventions.
    Guirguis K
    Consult Pharm; 2010 Jul; 25(7):433-9. PubMed ID: 20601348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.